Identifying the Factors Affecting Organizational Innovation in Pharmaceutical Companies with a Focus on the Economic Leap Approach
Keywords:
Organizational Innovation, Pharmaceutical Industry, Economic Leap, Absorptive Capacity, Human Capital, Organizational Culture, Research and Development, Digital TransformationAbstract
This study aimed to identify and explain the factors affecting organizational innovation in pharmaceutical companies listed on the Tehran Stock Exchange with a focus on the economic leap approach. The present study was applied in terms of purpose and qualitative in nature using thematic analysis, complemented by questionnaire data in the final stage. The research population consisted of senior managers, chief executive officers, and research and development managers of pharmaceutical companies listed on the Tehran Stock Exchange. Qualitative data were collected through 10 semi-structured interviews, and an online Porsline questionnaire was distributed among 25 pharmaceutical industry managers to validate and prioritize the findings. Data analysis was conducted through open, axial, and selective coding as well as thematic analysis. Questionnaire data were analyzed using descriptive statistics and factor ranking procedures. The findings revealed that organizational innovation in the Iranian pharmaceutical industry is influenced by seven major factors, including human capital, absorptive capacity of knowledge and technology, innovation-oriented organizational culture, investment in research and development, flexible organizational structure, external collaborations, and incremental low-cost innovation. Among these factors, human capital achieved the highest priority and was identified as the primary driver of organizational innovation. The results also demonstrated that absorptive capacity plays a critical role in exploiting technological opportunities and localizing external knowledge. Furthermore, a learning-oriented organizational culture characterized by adaptability, risk tolerance, and acceptance of failure was recognized as an essential platform for innovation development. The findings indicated that Iranian pharmaceutical companies tend to prioritize incremental and low-cost innovations and adopt a cautious approach toward external collaborations due to institutional and economic constraints. The results demonstrated that organizational innovation in Iranian pharmaceutical companies is shaped by the simultaneous interaction of human, technological, structural, and environmental factors. Achieving innovation success requires strengthening human capital, developing absorptive capacity, fostering an innovation-oriented culture, and strategically utilizing technological opportunities and external collaborations.
Downloads
References
Ajike, E. O., Adeleke, A. A., Bamidele, A. G., Olubiyi, T. O., Adesuyi, O. O., Ilori, G. E., Ariguzo, V. A., & Binuyo, B. O. (2024). The Moderating Role of Supply Chain Agility on the Relationship Between Strategic Flexibility and Organizational Market Performance in Nigerian Pharmaceutical Industry. PaperASIA, 40(5b), 337-349. https://doi.org/10.59953/paperasia.v40i5b.259
Ajike, E. O., Nwankwere, I. A., & Adeleke, A. A. (2023). The Moderating Effect of Marketing Competence on the Relationship Between Strategic Flexibility Organizational Performances of Quoted Pharmaceutical Companies in Nigeria. International Journal of Research in Finance and Management, 6(1), 353-363. https://doi.org/10.33545/26175754.2023.v6.i1d.225
Almeman, A. (2024). The Digital Transformation in Pharmacy: Embracing Online Platforms and the Cosmeceutical Paradigm Shift. Journal of Health Population and Nutrition, 43(1). https://doi.org/10.1186/s41043-024-00550-2
Asrif, M. I., Handayani, P. W., & Harahap, N. C. (2026). Indonesian organization digital innovation: the influence of business process management capabilities. Business Process Management Journal, 1-26.
Benavides, A. F. C., Ehrenhard, M., Visser, M. d., & Weerd-Nederhof, P. C. d. (2022). Interfirm Cooperatives Enabling Organizational Ambidexterity, a Case Study of the Printing Industry in Colombia. Thunderbird International Business Review, 64(5), 477-491. https://doi.org/10.1002/tie.22283
Carmine, B. (2022). The Evolution of High Tech Companies Over the Years: Some Definitions and Difference Between Market-Oriented Companies and Innovation-Oriented Companies. International Journal of Economics Business and Management Research, 06(12), 30-41. https://doi.org/10.51505/ijebmr.2022.61203
Christofi, M., Stylianou, I., Hadjielias, Ε., Massis, A. D., & Kastanakis, M. N. (2023). Tackling Pandemic‐related Health Grand Challenges: The Role of Organizational Ambidexterity, Social Equality, and Innovation Performance. Journal of Product Innovation Management, 41(2), 347-378. https://doi.org/10.1111/jpim.12662
Collington, R., & Lazonick, W. (2022). Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access. https://doi.org/10.36687/inetwp176
Damle, M., & Krishnamoorthy, B. (2022). Identifying Critical Drivers of Innovation in Pharmaceutical Industry Using TOPSIS Method. MethodsX, 9, 101677. https://doi.org/10.1016/j.mex.2022.101677
Gaitho, N. M., Kilika, J. M., & Muriuki, N. (2024). Investing in the Social Innovation for Sustainability: Identifying the Casual Effects in Pharmaceutical Distributors Targeting Informal Settlement Areas in Nairobi City, Kenya. International Journal of Research in Business and Social Science (2147-4478), 13(6), 52-66. https://doi.org/10.20525/ijrbs.v13i6.3418
Ibikunle, T. D., Akpa, V. O., & Nwankwere, I. (2023). Entrepreneurial Orientation and Financial Growth of Quoted Pharmaceutical Companies in Nigeria. Journal of Economics Finance and Management Studies, 06(05). https://doi.org/10.47191/jefms/v6-i5-60
Kim, E., In-Gyu, L., Kim, H., & Shin, K. (2021). Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals. Sustainability, 13(8), 4122. https://doi.org/10.3390/su13084122
Kim, S. J., Koo, I., Park, S., & Wang, Z. (2024). Schumpeterian Implications of Government-Led Local Innovation: Evidence From China. Science Technology and Society, 30(1), 30-52. https://doi.org/10.1177/09717218241304194
Llantada, B., & Pérez, P. J. (2022). Research on the Application of Information Technology in the Pharmaceutical Sector. Journal of Commercial Biotechnology, 27(2). https://doi.org/10.5912/jcb1298
Lozano, C. P., & Collazzo, P. (2021). Corporate Social Responsibility, Green Innovation and Competitiveness – Causality in Manufacturing. Competitiveness Review an International Business Journal, 32(7), 21-39. https://doi.org/10.1108/cr-12-2020-0160
Lozano, C. P., Padilla-Lozano, J., Ortiz, G. E. R., & Collazzo, P. (2024). Green Innovation and Competitiveness: Empirical Evidence From Ecuadorian Manufacturing. Management Research the Journal of the Iberoamerican Academy of Management, 22(3), 303-323. https://doi.org/10.1108/mrjiam-03-2023-1405
Molina, R. I. R., Acosta, M. V. P., Keren Daniela Viloria De la, H., Pérez, J. D. R., & Raby, N. D. L. (2023). Innovative Strategies in Agricultural Production Units: Knowledge in Development of New Services and Value Chains. Revista De La Universidad Del Zulia, 14(39), 119-138. https://doi.org/10.46925//rdluz.39.07
Mukucha, P., & Chari, F. (2023). The Moderating Effect of Farming Contracts on the Relationship Between Responsive Supply Chain Elements and Supply Chain Resilience. Journal of Future Sustainability, 3(1), 1-12. https://doi.org/10.5267/j.jfs.2022.11.001
Putri, L. T., Rahmawati, R., & Putri, D. L. (2022). Formation of an Entrepreneur Mindset in Creating Competitiveness of Female Entrepreneurs. International Journal of Social Science, 2(1), 1179-1186. https://doi.org/10.53625/ijss.v2i1.2363
Raza, S., Laghari, M. K., & Junejo, M. A. (2023). The Dynamics of Innovation on Firm Performance: Empirical Analysis of Pharmaceutical Manufacturing Firms in Sindh Pakistan. Pakistan Journal of Humanities and Social Sciences, 11(2). https://doi.org/10.52131/pjhss.2023.1102.0424
Saghafi, F., Mohaghar, A., & Kashiha, M. (2021). Developing a Catch-Up Model of Technology: A Grounded Theory Approach. Journal of Science and Technology Policy Management, 12(4), 627-650. https://doi.org/10.1108/jstpm-07-2019-0068
Saxena, K., Balani, S., & Srivastava, P. (2021). The Relationship Among Corporate Social Responsibility, Sustainability and Organizational Performance in Pharmaceutical Sector: A Literature Review. International Journal of Pharmaceutical and Healthcare Marketing, 15(4), 572-597. https://doi.org/10.1108/ijphm-12-2020-0104
Schuessler, E., Svejenova, S., & Cohendet, P. (2021). Organizing Creativity for Innovation: Situated Practices and Process Perspectives. 1-16. https://doi.org/10.1108/s0733-558x20210000075002
Shi, J. (2021). Research on Enterprise Platformization Based on Organizational Structure Reform——Taking SF Express as an Example. 203. https://doi.org/10.2991/assehr.k.211209.360
Su, Y., Khan, M. T., Ullah, S., Kukreti, M., Sami, A., & Dangwal, A. (2026). Steering the digital transformation: How paradoxical leadership juggles innovation culture and organizational agility. Human Systems Management, 45(3), 396-407. https://doi.org/10.1177/01672533251372833
Wahab, S. N., & Sahak, M. Y. (2023). Can Drug Price Controls Help Patients Get a Better Deal? A SWOT Analysis. Malaysian Journal of Medicine and Health Sciences, 19(6), 222-233. https://doi.org/10.47836/mjmhs.19.6.30
Zhang, L., Yu, Q., Jin, Z., & Xu, J. (2021). Do Intellectual Capital Elements Spur Firm Performance? Evidence From the Textile and Apparel Industry in China. Mathematical Problems in Engineering, 2021, 1-12. https://doi.org/10.1155/2021/7332885
Zhou, F., Zhang, N., Li, X., Han, C., & Gupta, B. B. (2025). Managing inter-organizational dependencies operation for discovering digital business model innovation in corporate innovation ecosystem. Operations Management Research, 18, 574-590. https://doi.org/10.1007/s12063-024-00501-4
Downloads
Published
Submitted
Revised
Accepted
Issue
Section
License
Copyright (c) 1405 Zahra Molavian Jazi (Author); Hamid Padash; Mohammad Khosravi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
